Table 1.
Dendrimers | Ligands | Targeting Pattern | Drug | Diseases | References |
---|---|---|---|---|---|
G5 PAMAM | Folic acid | Dual-functional glioma targeting | Borneol | Glioma | [116] |
G5 PAMAM | Lactoferrin | Targeting the BBB | Plasmid hGDNF | PD | [117,118] |
G5 PAMAM | Lactoferrin | Targeting the BBB | pEGFP-N2, pGL2 | - | [119,120] |
G5 PAMAM | Transferrin | Targeting the BBB | pEGFP-N2, pGL2 | - | [121] |
G5 PAMAM | HAIYPRH peptide | Targeting the BBB and tumor cells | pORF-hTRAIL, doxorubicin | Glioma | [122] |
G4 PAMAM | Transferrin, Tamoxifen | Dual targeting to the BBB and tumor cells | Doxorubicin | Glioma | [123] |
G5 PAMAM | Angiopep-2 peptide | Dual targeting to the BBB and tumor cells | pORF-hTRAIL, pGL2 | Glioma | [124] |
G5 PAMAM | Angiopep-2 peptide | Targeting to the BBB | pEGFP-N2 | - | [125] |
G5 PAMAM | RVG29 peptide | Targeting to the BBB | pEGFP-N2, pGL2 | - | [126] |
G5 PAMAM | Chlorotoxin | Targeting to tumor cells | pORF-hTRAIL | Glioma | [127] |
G4 PAMAM | SRL peptide | Targeting to the BBB | pEGFP-N2 | - | [128] |
G4 PAMAM derivate | - | - | HMGB1 siRNA | Cerebral ischemia | [91] |
G3 PPI | Transferrin | Targeting to the BBB | pGL | Glioma | [114] |
G5 PPI | Sialic acid | Targeting to the BBB | Paclitaxel | - | [112] |
G5 PPI | Polysorbate 80 | Targeting to the BBB | Docetaxel | Glioma | [129] |
G3 DGL | HAIYPRH (T7) peptide | Dual targeting to the BBB and tumor cells | pORF-hTRAIL, doxorubicin | Glioma | [130] |
G3 DGL | HAIYPRH (T7) peptide | Dual targeting to the BBB and tumor cells | siRNA for luciferase | Glioma | [131] |
G3 DGL | Angiopep peptide | Targeting to the BBB | Plasmid hGDNF | PD | [132] |
G3 DGL | Choline derivate | Targeting to the BBB | pGL3 | - | [133] |
G3 DGL | Choline derivate | Dual targeting to the BBB and tumor cells | pORF-hTRAIL and doxorubicin | Glioma | [134] |
G3 DGL | NL4 peptide, apolipoprotein A-I | Dual targeting to the BBB and neurons | BACE1 siRNA | AD | [135] |
G3 DGL | Transferrin, MAN | Dual targeting to the BBB and tumor cells | Doxorubicin | Glioma | [136] |
PEI-PLL | Angiopep-2 | Dual targeting to the BBB and tumor cells | HSV-TK plasmid | Glioma | [137] |
PEI-PLL | - | Targeting to dopaminergic neurons | VEGF plasmid | PD | [138] |
Carbosilane dendrimer | - | Targeting to the primary astrocytes | siRNA against HIV-1 Nef | HIV | [139] |
Amino-functional polyester dendrimers | - | Targeting to the BBB | siRNA | Astrocytes, glioma cells | [140] |
PAMAM, polyamidoamine; PPI, polypropyleneimine; hGDNF, human glial-derived neurotrophic factor gene; PD, Parkinson’s disease; EGFP, enhanced green fluorescent protein; HAIYPRH (T7), a TfR-targeting peptide, having a high affinity for the TfR with a Kd of ~10 nM; pORF-hTRAIL, a therapeutic gene encoding human tumor necrosis factor-related apoptosis-inducing ligand; pGL, a report gene encoding wildtype firefly luciferase; HMGB1, high mobility group box-1; NL4, a peptide which can bind with tyrosine kinases A; RVG29, a 29-amonic acid peptide derived from rabies virus glycoprotein; DGL, dendri-grafted poly-l-lysine; SRL, Serine–Arginine–Leucine; BACE1, beta-amyloid converting enzyme 1; AD, Alzheimer’s disease; HSV-TK, herpes simplex virus type I thymidine kinase gene; VEGF, vascular endothelial growth factor; MAN, P-aminophenyl-α-d-mannopyranoside.